ReviewWorld journal of oncology2026

Advances in Targeted Therapy for Human Epidermal Growth Factor Receptor 2-Low Tumors: From Trastuzumab to Antibody-Drug Conjugates.

Zhi Nuo Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.